Moderna's market capitalization reaches 3.6 times that of BioNTech
MRNA Moderna Inc
$213.74 -5.00%
View chart & analysis → 
- 1Moderna's stock price has recorded a year-to-date increase of over 660%.
- 2BioNTech's market capitalization of less than $25 billion is lower than Moderna's $90 billion.
- 3In the last 3 months, 11 analysts have recommended a buy for BioNTech.
So what's the key point?
Moderna's value has become 3.6 times larger than BioNTech's. Experts say it is a good idea to buy BioNTech stock.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.